Aripiprazole joins the family of second-generation mood stabilizers

Journal of Clinical Psychiatry

Volumn 69, Issue 5, 2008, Pages 862-863

  Rybakowski, Janusz K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CARBAMAZEPINE; CLOZAPINE; FLUOXETINE; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; VALPROIC ACID DERIVATIVE;

BIPOLAR DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DEPRESSION; DRUG EFFICACY; HUMAN; LETTER; MANIA; MOLECULAR GENETICS; MONOTHERAPY; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 45249103318     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0522b     Document Type: Letter

References (24)

1. Rybakowski JK. Two generations of mood stabilizers [letter]. Int J Neuropsychopharmacol 2007;10:709-711
2. Keck PE Jr, Calabrese JR, McIntyre RS, et al. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry 2007 Oct;68(10):1480-1491
3. Hartigan GP. The use of lithium salts in affective disorders. Br J Psychiatry 1963;109:810-814
4. Baastrup PC. The use of lithium in manic-depressive psychosis. Compr Psychiatry 1964 Dec;10:396-408
5. Lambert PA, Carraz G, Borselli S, et al. Action neuropsychotrope d'un nouvel anti-epileptique: le depamide. Ann Med Psychol 1966;1:707-710
6. Lambert PA, Borselli S, Marcou G, et al. Action thymoregulatrice a long terme de Depamide dans la psychose maniaco-depressive. Ann Med Psychol 1971;2:442-447
7. Takezaki H, Hanaoka M. The use of carbamazepine in the control of manic-depressive psychosis and other manic-depressive states. Clin Psychiatry 1971;13:173-183
8. Okuma T, Kishimoto A, Inoue K, et al. Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis: a preliminary report. Folia Psychiatr Neurol Jpn 1973;27:283-297
9. Williams RS, Cheng L, Mudge AW, et al. A common mechanism of action for three mood-stabilizing drugs. Nature 2002;417:292-295
10. Baum AE, Akula N, Cabanero M, et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2008 Feb;13(2):197-207
11. Zarate CA Jr, Tohen M, Banov MD, et al. Is clozapine a mood stabilizer? J Clin Psychiatry 1995;56:108-112
12. Ketter TA, Calabrese JR. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J Clin Psychiatry 2002;63:146-151
13. Calabrese JR, Kimmel SE, Woyshville MJ, et al. Clozapine for treatment-refractory mania. Am J Psychiatry 1996;153:759-764
14. Ciapparelli A, Dell'Osso L, Bandettini di Poggio A, et al. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study. J Clin Psychiatry 2003;64:451-458
15. Perlis RH, Welge JA, Vornik LA, et al. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry 2006;67:509-516
16. Vieta E, Rosa AR. Evolving trends in the long-term treatment of bipolar disorder. World J Biol Psychiatry 2007;8:4-11
17. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003;60:1079-1088
18. Calabrese JR, Keck PE Jr, McFadden W, et al. A randomized-double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005;162:1351-1360
19. Ketter TA, Wang PW, Chandler RA, et al. Adjunctive aripiprazole in treatment-resistant depression. Ann Clin Psychiatry 2006;18:169-172
20. Rapaport MH, Gharabawi GM, Canuso CM, et al. Effect of risperidone augmentation in patients with treatment-resistant depression: results of open-label treatment followed by double-blind continuation. Neuropsychopharmacology 2006;31:2505-2513
21. Dunner DL, Amsterdam JD, Shelton RC, et al. Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study. J Clin Psychiatry 2007;68:1071-1077
22. Rybakowski JK, Chlopocka-Wozniak M, Suwalska A. The propylactic effect of long-term lithium administration in bipolar patients entering lithium treatment in the 1970s and 1980s. Bipolar Disord 2001;3:63-67
23. Ganham J, Munro A, Slaney C, et al. Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study. J Affect Disord 2007;104:185-190
24. Passmore MJ, Garnham J, Duffy A, et al. Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disord 2003;5:110-114